Verbal working memory in schizophrenia from the Consortium on the Genetics of Schizophrenia (COGS) Study: The moderating role of smoking status and antipsychotic medications

Schizophrenia Research

Volumn 163, Issue 1-3, 2015, Pages 24-31

  Lee, Junghee ^a,b   Green, Michael F ^a,b   Calkins, Monica E ^c   Greenwood, Tiffany A ^d   Gur, Raquel E ^c   Gur, Ruben C ^c   Lazzeroni, Laura C ^e   Light, Gregory A ^d,f   Nuechterlein, Keith H ^a   Radant, Allen D ^g,h   Seidman, Larry J ^i,j   Siever, Larry J ^k,l   Silverman, Jeremy M ^k,l   Sprock, Joyce ^d,f   Stone, William S ^i,j   Sugar, Catherine A ^a,b,m   Swerdlow, Neal R ^d   Tsuang, Debby W ^g,h   Tsuang, Ming T ^d,n   Turetsky, Bruce I ^c   Braff, David L ^d,f   more..

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA GREATER LOS ANGELES HEALTHCARE SYSTEM   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e STANFORD UNIVERSITY   (United States)

^f VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^g UNIVERSITY OF WASHINGTON   (United States)

^h VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

ⁱ HARVARD MEDICAL SCHOOL   (United States)

^j BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^k MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^l VETERANS AFFAIRS MEDICAL CENTER   (United States)

^m UNIVERSITY OF CALIFORNIA   (United States)

ⁿ HARVARD UNIVERSITY   (United States)

more..

Author keywords

Antipsychotic medication; Letter Number span; Moderators; Schizophrenia; Smoking; Verbal working memory

Indexed keywords

NEUROLEPTIC AGENT;

ADULT; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DRUG USE; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEMORY DISORDER; MENTAL CAPACITY; MENTAL TASK; NERVE STIMULATION; PRIORITY JOURNAL; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SMOKING HABIT; STIMULUS RESPONSE; SUBSTANCE ABUSE; VERBAL MEMORY; WORKING MEMORY; CLINICAL TRIAL; COMPLICATION; DRUG EFFECTS; ENDOPHENOTYPE; FAMILY; GENETICS; LEARNING; MIDDLE AGED; MULTICENTER STUDY; NEUROPSYCHOLOGICAL TEST; PATHOPHYSIOLOGY; PSYCHOLOGY; PSYCHOTIC DISORDERS; RECALL; RECOGNITION; SHORT TERM MEMORY; SMOKING; SPEECH PERCEPTION; YOUNG ADULT;

ADULT; ANTIPSYCHOTIC AGENTS; CASE-CONTROL STUDIES; ENDOPHENOTYPES; FAMILY; FEMALE; HUMANS; MALE; MEMORY, SHORT-TERM; MENTAL RECALL; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHOTIC DISORDERS; RECOGNITION (PSYCHOLOGY); SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SMOKING; SPEECH PERCEPTION; VERBAL LEARNING; YOUNG ADULT;

EID: 84925874805     PISSN: 09209964     EISSN: 15732509     Source Type: Journal    
DOI: 10.1016/j.schres.2014.08.014     Document Type: Article

References (65)

1. Addy N., Levin E.D. Nicotine interactions with haloperidol, clozapine and risperidone and working memory function in rats. Neuropsychopharmacology 2002, 27(4):534-541.
2. Andreasen N.C. The scale for the assessment of negative symptoms (SANS) 1984, The University of Iowa, Iowa City, IA.
3. Andreasen N.C. The scale for the assessment of positive symptoms (SAPS) 1984, The University of Iowa, Iowa City, IA.
4. Baddeley A.D. Working memory. Science 1992, 255:556-559.
5. Barr R.S., Culhane M.A., Jubelt L.E., Mufti R.S., Dyer M.A., Weiss A.P., Deckersbach T., Kelly J.F., Freudenreich O., Goff D.C., Evins A.E. The effects of transdermal nicotine on cognition in nonsmokers with schizophrenia and nonpsychiatric controls. Neuropsychopharmacology 2008, 33(3):480-490.
6. Bittner R.A., Linden D.E., Roebroeck A., Hartling F., Rotarska-Jagiela A., Maurer K., Goebel R., Singer W., Haenschel C. The when and where of working memory dysfunction in early-onset schizophrenia--a functional magnetic resonance imaging study. Cereb. Cortex 2014, (in press).
7. Brody A.L., Mandelkern M.A., Olmstead R.E., Allen-Martinez Z., Scheibal D., Abrams A.L., Costello M.R., Farahi J., Saxena S., Monterosso J., London E.D. Ventral striatal dopamine release in response to smoking a regular vs a denicotinized cigarette. Neuropsychopharmacology 2009, 34(2):282-289.
8. Bruijnzeel A.W., Markou A. Decreased sensitivity to the effects of dopamine D1-like, but not D2-like, receptor antagonism in the posterior hypothalamic region/anterior ventral tegmental area on brain reward function during chronic exposure to nicotine in rats. Brain Res. 2005, 1058(1-2):91-100.
9. Castner S.A., Williams G.V., Goldman-Rakic P.S. Reversal of antipsychotic-induced working memory deficits by short-term dopamine D1 receptor stimulation. Science 2000, 287(5460):2020-2022.
10. Chamberlain S.R., Odlaug B.L., Schreiber L.R., Grant J.E. Association between tobacco smoking and cognitive functioning in young adults. Am. J. Addict. 2012, 21(Suppl. 1):S14-S19.
11. Cohen J.E. Statistical power analysis for the behavioral science 1988, Lawrence Erlbaum Associates, Inc., Hilsdale, HJ.
12. Coleman M.J., Krastoshevsky O., Tu X., Mendell N.R., Levy D.L. The effects of perceptual encoding on the magnitude of object working memory impairment in schizophrenia. Schizophr. Res. 2012, 139(1-3):60-65.
13. Cullen K.R., Wallace S., Magnotta V.A., Bockholt J., Ehrlich S., Gollub R.L., Manoach D.S., Ho B.C., Clark V.P., Lauriello J., Bustillo J.R., Schulz S.C., Andreasen N.C., Calhoun V.D., Lim K.O., White T. Cigarette smoking and white matter microstructure in schizophrenia. Psychiatry Res. 2012, 201(2):152-158.
14. Donoghue K., Mazzoncini R., Hart J., Zanelli J., Morgan C., Dazzan P., Morgan K.D., Murray R.M., Jones P.B., Doody G.A. The differential effect of illicit drug use on cognitive function in first-episode psychosis and healthy controls. Acta Psychiatr. Scand. 2012, 125(5):400-411.
15. D'Souza D.C., Ahn K., Bhakta S., Elander J., Singh N., Nadim H., Jatlow P., Suckow R.F., Pittman B., Ranganathan M. Nicotine fails to attenuate ketamine-induced cognitive deficits and negative and positive symptoms in humans: implications for schizophrenia. Biol. Psychiatry 2012, 72(9):785-794.
16. Ersche K.D., Clark L., London M., Robbins T.W., Sahakian B.J. Profile of executive and memory function associated with amphetamine and opiate dependence. Neuropsychopharmacology 2006, 31(5):1036-1047.
17. Falcone M., Wileyto E.P., Ruparel K., Gerraty R.T., Laprate L., Detre J.A., Gur R., Loughead J., Lerman C. Age-related differences in working memory deficits during nicotine withdrawal. Addict. Biol. 2014, 19(5):907-917.
18. George T.P., Vessicchio J.C., Termine A., Sahady D.M., Head C.A., Pepper W.T., Kosten T.R., Wexler B.E. Effects of smoking abstinence on visuospatial working memory function in schizophrenia. Neuropsychopharmacology 2002, 26(1):75-85.
19. Glahn D.C., Therman S., Manninen M., Huttunen M., Kaprio J., Lonnqvist J., Cannon T.D. Spatial working memory as an endophenotype for schizophrenia. Biol. Psychiatry 2003, 53(7):624-626.
20. Glahn D.C., Ragland J.D., Abramoff A., Barrett J., Laird A.R., Bearden C.E., Velligan D.I. Beyond hypofrontality: a quantitative meta-analysis of functional neuroimaging studies of working memory in schizophrenia. Hum. Brain Mapp. 2005, 25:60-69.
21. Gold J.M., Carpenter C., Randolph C., Goldberg T.E., Weinberger D.R. Auditory working memory and Wisconsin Card Sorting Test performance in schizophrenia. Arch. Gen. Psychiatry 1997, 54(2):159-165.
22. Green M.F., Kern R.S., Braff D.L., Mintz J. Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"?. Schizophr. Bull. 2000, 26:119-136.
23. Green M.F., Nuechterlein K.H., Gold J.M., Barch D.M., Cohen J., Essock S., Fenton W.S., Frese F., Goldberg T.E., Heaton R.K., Keefe R.S.E., Kern R.S., Kraemer H., Stover E., Weinberger D.R., Zalcman S., Marder S.R. Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria. Biol. Psychiatry 2004, 56:301-307.
24. Green M.F., Nuechterlein K.H., Kern R.S., Baade L.E., Fenton W.S., Gold J.M., Keefe R.S.E., Mesholam-Gately R., Seidman L.J., Stover E., Marder S.R. Functional co-primary measures for clinical trials in schizophrenia: results from the MATRICS psychometric and standardization study. Am. J. Psychiatr. 2008, 165:221-228.
25. Greenwood T.A., Lazzeroni L.C., Murray S.S., Cadenhead K.S., Calkins M.E., Dobie D.J., Green M.F., Gur R.E., Gur R.C., Hardiman G., Kelsoe J.R., Leonard S., Light G.A., Nuechterlein K.H., Olincy A., Radant A.D., Schork N.J., Seidman L.J., Siever L.J., Silverman J.M., Stone W.S., Swerdlow N.R., Tsuang D.W., Tsuang M.T., Turetsky B.I., Freedman R., Braff D.L. Analysis of 94 candidate genes and 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am. J. Psychiatry 2011, 168(9):930-946.
26. Greenwood T.A., Swerdlow N.R., Gur R.E., Cadenhead K.S., Calkins M.E., Dobie D.J., Freedman R., Green M.F., Gur R.C., Lazzeroni L.C., Nuechterlein K.H., Olincy A., Radant A.D., Ray A., Schork N.J., Seidman L.J., Siever L.J., Silverman J.M., Stone W.S., Sugar C.A., Tsuang D.W., Tsuang M.T., Turetsky B.I., Light G.A., Braff D.L. Genome-wide linkage analyses of 12 endophenotypes for schizophrenia from the Consortium on the Genetics of Schizophrenia. Am. J. Psychiatry 2013, 170(5):521-532.
27. Grinevich V.P., Papke R.L., Lippiello P.M., Bencherif M. Atypical antipsychotics as noncompetitive inhibitors of alpha4beta2 and alpha7 neuronal nicotinic receptors. Neuropharmacology 2009, 57(2):183-191.
28. Hall R.C. Global assessment of functioning. A modified scale. Psychosomatics 1995, 36(3):267-275.
29. Hartz S.M., Pato C.N., Medeiros H., Cavazos-Rehg P., Sobell J.L., Knowles J.A., Bierut L.J., Pato M.T. Comorbidity of severe psychotic disorders with measures of substance use. JAMA Psychiatry 2014, 71(3):248-254.
30. Harvey P.D., Raykov T., Twamley E.W., Vella L., Heaton R.K., Patterson T.L. Validating the measurement of real-world functional outcomes: phase I results of the VALERO study. Am. J. Psychiatry 2011, 168(11):1195-1201.
31. Horan W.P., Braff D.L., Nuechterlein K.H., Sugar C.A., Cadenhead K.S., Calkins M.E., Dobie D.J., Freedman R., Greenwood T.A., Gur R.E., Gur R.C., Light G.A., Mintz J., Olincy A., Radant A.D., Schork N.J., Seidman L.J., Siever L.J., Silverman J.M., Stone W.S., Swerdlow N.R., Tsuang D.W., Tsuang M.T., Turetsky B.I., Green M.F. Verbal working memory impairments in individuals with schizophrenia and their first-degree relatives: findings from the Consortium on the Genetics of Schizophrenia. Schizophr. Res. 2008, 103(1-3):218-228.
32. Jacobsen L.K., D'Souza D.C., Mencl W.E., Pugh K.R., Skudlarski P., Krystal J.H. Nicotine effects on brain function and functional connectivity in schizophrenia. Biol. Psychiatry 2004, 55(8):850-858.
33. Jacobsen L.K., Krystal J.H., Mencl W.E., Westerveld M., Frost S.J., Pugh K.R. Effects of smoking and smoking abstinence on cognition in adolescent tobacco smokers. Biol. Psychiatry 2005, 57(1):56-66.
34. Lee J., Park S. Working memory impairments in schizophrenia: a meta-analysis. J. Abnorm. Psychol. 2005, 114(4):599-611.
35. Loughead J., Wileyto E.P., Valdez J.N., Sanborn P., Tang K., Strasser A.A., Ruparel K., Ray R., Gur R.C., Lerman C. Effect of abstinence challenge on brain function and cognition in smokers differs by COMT genotype. Mol. Psychiatry 2009, 14(8):820-826.
36. Marenco S., Carson R.E., Berman K.F., Herscovitch P., Weinberger D.R. Nicotine-induced dopamine release in primates measured with [11C]raclopride PET. Neuropsychopharmacology 2004, 29(2):259-268.
37. Mausbach B.T., Harvey P.D., Goldman S.R., Jeste D.V., Patterson T.L. Development of a brief scale of everyday functioning in persons with serious mental illness. Schizophr. Bull. 2007, 33(6):1364-1372.
38. Mayer J.S., Fukuda K., Vogel E.K., Park S. Impaired contingent attentional capture predicts reduced working memory capacity in schizophrenia. PLoS ONE 2012, 7(11):e48586.
39. McPheeters H.L. Statewide mental health outcome evaluation: a perspective of two southern states. Community Ment. Health J. 1984, 20(1):44-55.
40. Mitropoulou V., Harvey P.D., Zegarelli G., New A.S., Silverman J.M., Siever L.J. Neuropsychological performance in schizotypal personality disorder: importance of working memory. Am. J. Psychiatry 2005, 162(10):1896-1903.
41. Nuechterlein K.H., Barch D.M., Gold J.M., Goldberg T.E., Green M.F., Heaton R.K. Identification of separable cognitive factors in schizophrenia. Schizophr. Res. 2004, 72:29-39.
42. Park S., Knopick C., McGurk S., Meltzer H.Y. Nicotine impairs spatial working memory while leaving spatial attention intact. Neuropsychopharmacology 2000, 22(2):200-209.
43. Pukrop R., Matuschek E., Ruhrmann S., Brockhaus-Dumke A., Tendolkar I., Bertsch A., Klosterkotter J. Dimensions of working memory dysfunction in schizophrenia. Schizophr. Res. 2003, 62(3):259-268.
44. Regier D.A., Farmer M.E., Rae D.S., Locke B.Z., Keith S.J., Judd L.L., Goodwin F.K. Comorbidity of mental disorders with alcohol and other drug abuse. Results from the Epidemiologic Catchment Area (ECA) Study. JAMA 1990, 264(19):2511-2518.
45. Reilly J.L., Harris M.S., Keshavan M.S., Sweeney J.A. Adverse effects of risperidone on spatial working memory in first-episode schizophrenia. Arch. Gen. Psychiatry 2006, 63(11):1189-1197.
46. Reilly J.L., Harris M.S., Khine T.T., Keshavan M.S., Sweeney J.A. Antipsychotic drugs exacerbate impairment on a working memory task in first-episode schizophrenia. Biol. Psychiatry 2007, 62(7):818-821.
47. Sabia S., Marmot M., Dufouil C., Singh-Manoux A. Smoking history and cognitive function in middle age from the Whitehall II study. Arch. Intern. Med. 2008, 168(11):1165-1173.
48. Sacco K.A., Termine A., Seyal A., Dudas M.M., Vessicchio J.C., Krishnan-Sarin S., Jatlow P.I., Wexler B.E., George T.P. Effects of cigarette smoking on spatial working memory and attentional deficits in schizophrenia: involvement of nicotinic receptor mechanisms. Arch. Gen. Psychiatry 2005, 62(6):649-659.
49. Schnell T., Koethe D., Daumann J., Gouzoulis-Mayfrank E. The role of cannabis in cognitive functioning of patients with schizophrenia. Psychopharmacology 2009, 205(1):45-52.
50. Seidman L.J., Hellemann G.S., Nuechterlein K.H., Braff D.L., Greenwood T.A., Cadenhead K.S., Calkins M.E., Freedman R., Gur R.E., Gur R.C., Lazzeroni L.C., Light G.A., Olincy A., Radant A.D., Siever L.J., Silverman J.M., Stone W.S., Sprock J., Sugar C., Swerdlow N.R., Tsuang D.W., Tsuang M.T., Turetsky B.I., Green M.F. Factor structure and heritability of endophenotypes in schizophrenia: findings from the Consortium on the Genetics of Schizophrenai (COGS- 1), 2015, 163(1-3):9-16.
51. Smith C.W., Park S., Cornblatt B. Spatial working memory deficits in adolescents at clinical high risk for schizophrenia. Schizophr. Res. 2006, 81(2-3):211-215.
52. Swerdlow N.R., Gur R., Braff D.L. Consortium on the Genetics of Schizophrenia (COGS) Assessment of Endophenotypes for schizophrenia: an introduction to this special issue of schizophrenia research. Schizophr. Res. 2014, (submitted for publication).
53. Tan H.Y., Callicott J.H., Weinberger D.R. Dysfunctional and compensatory prefrontal cortical systems, genes and the pathogenesis of schizophrenia. Cereb. Cortex 2007, 17(Suppl. 1):i171-i181.
54. Thoma P., Daum I. Working memory and multi-tasking in paranoid schizophrenia with and without comorbid substance use disorder. Addiction 2008, 103(5):774-786.
55. Tsukada H., Miyasato K., Nishiyama S., Fukumoto D., Kakiuchi T., Domino E.F. Nicotine normalizes increased prefrontal cortical dopamine D1 receptor binding and decreased working memory performance produced by repeated pretreatment with MK-801: a PET study in conscious monkeys. Neuropsychopharmacology 2005, 30(12):2144-2153.
56. Tunbridge E.M., Harrison P.J., Weinberger D.R. Catechol-o-methyltransferase, cognition, and psychosis: Val158Met and beyond. Biol. Psychiatry 2006, 60(2):141-151.
57. Twamley E.W., Doshi R.R., Nayak G.V., Palmer B.W., Golshan S., Heaton R.K., Patterson T.L., Jeste D.V. Generalized cognitive impairments, ability to perform everyday tasks, and level of independence in community living situations of older patients with psychosis. Am. J. Psychiatr. 2002, 159(12):2013-2020.
58. Vesterager L., Christensen T.O., Olsen B.B., Krarup G., Melau M., Forchhammer H.B., Nordentoft M. Cognitive and clinical predictors of functional capacity in patients with first episode schizophrenia. Schizophr. Res. 2012, 141(2-3):251-256.
59. Wagner M., Schulze-Rauschenbach S., Petrovsky N., Brinkmeyer J., von der Goltz C., Grunder G., Spreckelmeyer K.N., Wienker T., Diaz-Lacava A., Mobascher A., Dahmen N., Clepce M., Thuerauf N., Kiefer F., de Millas J.W., Gallinat J., Winterer G. Neurocognitive impairments in non-deprived smokers-results from a population-based multi-center study on smoking-related behavior. Addict. Biol. 2013, 18(4):752-761.
60. Wareing M., Fisk J.E., Murphy P.N. Working memory deficits in current and previous users of MDMA ('ecstasy'). Br. J. Psychol. 2000, 91(Pt 2):181-188.
61. Wechsler D. Wechsler Memory Scale 1997, The Psychological Corporation, San Antonio, TX. 3rd ed.
62. Wojtalik J.A., Barch D.M. An FMRI study of the influence of a history of substance abuse on working memory-related brain activation in schizophrenia. Front. Psychiatry 2014, 5:1.
63. Yucel M., Bora E., Lubman D.I., Solowij N., Brewer W.J., Cotton S.M., Conus P., Takagi M.J., Fornito A., Wood S.J., McGorry P.D., Pantelis C. The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample. Schizophr. Bull. 2012, 38(2):316-330.
64. Zammit S., Allebeck P., Dalman C., Lundberg I., Hemmingsson T., Lewis G. Investigating the association between cigarette smoking and schizophrenia in a cohort study. Am. J. Psychiatry 2003, 160(12):2216-2221.
65. Zhang X., Stein E.A., Hong L.E. Smoking and schizophrenia independently and additively reduce white matter integrity between striatum and frontal cortex. Biol. Psychiatry 2010, 68(7):674-677.